Knowledge and Perception of Pharmacy Practitioners toward Sustained Release Dosage Forms in Benghazi Community Pharmacies
Abstract
Background: The term sustained release dosage form is used to describe the delivery system which slowly releases the drug in the circulation over a prolonged period of time. Sustained release formulations have many advantages over immediate release dosage forms. For instance, improvement of patient's compliance due to reduction in dose frequency. This study was carried out to evaluate and compare the knowledge and perception of pharmacy practitioners toward the sustained release medications in Benghazi community pharmacies.                                                                                                         . Â
Method: A cross sectional survey was conducted during January and February 2018 by distributing a questionnaire to a selected study sample of pharmacy practitioners. The collected data were analyzed using the Statistical Package for Social Sciences.                    .
Results and discussion: The results demonstrated that oral sustained release medications are the most available and dispensed type in community pharmacies, where the central nervous system drugs accounted for the highest percentage then the cardiovascular system drugs (mainly angina). Interestingly, about (45%) of participants did not know the reasons for the presence of a few number of sustained release medications in the community pharmacies, and there was a significant difference between the participants (P = 0.004). Additionally, (41%) of participants believed that any drug can be formulated as a sustained release dosage form and there was no a significant difference between different groups of participants (P = 0.90).                                                                                                           .)
Conclusion: The majority of pharmacy practitioners seem to have a good knowledge toward the sustained release dosage forms but there is a lack of knowledge in some concepts. The higher cost of the single course therapy of sustained release medications in comparison with immediate release medications can be compensated by better disease management and less drug side effectsReferences
[2]. Zaid, A. Attitude and perception of patients and health care practitioners toward oral sustained release dosage forms in Palestine. Saudi Pharma J, 2010. 18: p. 251-256.
[3]. Pundir, S., Badola, A., Sharma, D. Sustained release matrix technology and recent advance in matrix drug delivery system: A Review. Int. J. Drug Res. Tech, 2013. 3: p. 12-20.
[4]. Shargel, L., Yu, A. Modified release drug products. Applied Biopharmaceutics and Pharmacokinetics, 4th ed., McGraw Hill, 1999. p.169-171.
[5]. Lachman, L., Lieberman, H. A., Kanig, J. L. The theory and practice of industrial pharmacy. 2nd ed, Bombay: Varghese publishing house, 1996. p. 171-196.
[6]. Sathish, U., Shravani, N. G., Raghavendra, R., Srikanth, M., Nayak, S. Overview on Controlled Release Dosage Form. Inter J of Pharma Sci, 2013. 3: p. 258-269.
[7]. Vyas, S.P., Khar, R.K. Controlled Drug delivery: Concepts and Advances. 1st ed, New Delhi: Vallabh prakashan, 2002. p.156-189.
[8]. Cornish, P. Medication safety: ‘‘Avoid the crush’’: hazards of medication administration in patients with dysphagia or a feeding tube. CMAJ, 2005. 172 (7): p. 871–872.
[9]. Welling, P. G., Dobrinska, M. R. Controlled drug delivery; fundamentals and applications. In: Robinson, J. R., Lee, V. L., (editors). Dosing consideration and bioavailability assessment of controlled drug delivery system. New York: Marcel Dekker Inc, 1978. 29: p. 254-373.
[10]. Ansel, C.H. Pharmaceutical Dosage Forms and Drug Delivery Systems. 6th ed, New Delhi: B.I. Waverly Pvt. Ltd, 1995. p. 213.
[11]. Lachman, L., Lieberman, A. Compression coated and layer tablets. In: Pharmaceutical Dosage Forms: Tablets. 2nd ed, New York: Marcel Dekker Inc, 2002. p. 84 – 247.
